Diet, Hepcidin, and Chemotherapy RDI

Inclusion Criteria: * Have been diagnosed with invasive breast cancer, OR * Have been diagnosed with epithelial ovarian cancer, fallopian tube or primary peritoneal cancer, OR * Have been diagnosed with endometrial cancer * Are chemotherapy-naïve * Are scheduled to receive neoadjuvant chemotherapy (or adjuvant chemotherapy following lumpectomy for breast cancer patients) or neoadjuvant/induction chemotherapy for gynecological cancer at GW Cancer Center Exclusion Criteria: * Prior primary hematological condition that would cause abnormal blood counts (e.g. leukemia) * Pregnant at the time of potential enrollment * Receipt of erythropoietin-stimulating agents or blood transfusion in the 6 weeks prior to initial testing * Women who are cognitively unable to provide a diet history for the month prior to assessment.